Active	Status	Sponsor type	Region	Phase	Filter
5 Active 2 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jian, Zhang
NCT05598268: A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.	Recruiting	1/2	74	RoW	T3011	ImmVira Pharma Co. Ltd	Advanced Solid Tumor, Lung Cancer, Liver Cancer, Lymphoma, Mesothelioma of Pleura	06/24	12/24
NCT05990452: Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors	Active, not recruiting	1/2	261	RoW	9MW2921	Mabwell (Shanghai) Bioscience Co., Ltd.	Advanced Solid Tumor	09/26	12/26
NCT05810103: A Study of DP303c in Patients With HER2-positive Advanced Solid Tumors	Recruiting	1	12	RoW	DP303c	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	HER2-positive Advanced Solid Tumors	12/23	03/24
NCT06158477: A Clinical Trial Evaluating JYP0035 Capsule Monotherapy in Patients With Advanced Solid Tumors	Recruiting	1	75	RoW	JYP0035 Experimental Drug Treatment	Chengdu JOYO pharma Co., Ltd., Guangzhou JOYO Pharma Co., Ltd	Advanced Solid Tumors	12/26	12/27
NCT06426680: A Study of the ILB-3101 in Patients with Advanced Solid Tumors	Recruiting	1	240	RoW	ILB-3101	Innolake Biopharm	Advanced Solid Tumor	12/25	03/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jian, Zhang
NCT05598268: A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.	Recruiting	1/2	74	RoW	T3011	ImmVira Pharma Co. Ltd	Advanced Solid Tumor, Lung Cancer, Liver Cancer, Lymphoma, Mesothelioma of Pleura	06/24	12/24
NCT05990452: Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors	Active, not recruiting	1/2	261	RoW	9MW2921	Mabwell (Shanghai) Bioscience Co., Ltd.	Advanced Solid Tumor	09/26	12/26
NCT05810103: A Study of DP303c in Patients With HER2-positive Advanced Solid Tumors	Recruiting	1	12	RoW	DP303c	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	HER2-positive Advanced Solid Tumors	12/23	03/24
NCT06158477: A Clinical Trial Evaluating JYP0035 Capsule Monotherapy in Patients With Advanced Solid Tumors	Recruiting	1	75	RoW	JYP0035 Experimental Drug Treatment	Chengdu JOYO pharma Co., Ltd., Guangzhou JOYO Pharma Co., Ltd	Advanced Solid Tumors	12/26	12/27
NCT06426680: A Study of the ILB-3101 in Patients with Advanced Solid Tumors	Recruiting	1	240	RoW	ILB-3101	Innolake Biopharm	Advanced Solid Tumor	12/25	03/26